z-logo
open-access-imgOpen Access
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome
Author(s) -
Ève Zakine,
Bérénice Schell,
Maxime Battistella,
MarieDominique VigPennamen,
François Chasset,
T. Mahévas,
F. Cordoliani,
Lionel Adès,
Marie Sébert,
J. Delaleu,
M. Jachiet,
C. Lepelletier,
Pierre Lemaire,
Clémentine Chauvel,
Bedis Dhouaieb,
Rathana Kim,
C. Cassius,
Sophie GeorginLavialle,
A. Mékinian,
Martine Bagot,
Thorsten Braun,
L. Rousset,
É. Bégon,
Adèle de Masson,
Pierre Fenaux,
Emmanuelle Clappier,
JeanDavid Bouaziz
Publication year - 2021
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2021.3344
Subject(s) - medicine , pathology , bone marrow , myeloid , dermatology
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a recently described severe adult-onset autoinflammatory disease that is associated with myeloid lineage-restricted ubiquitin-activating enzyme 1 (UBA1) somatic variations that primarily affect the skin (Sweet syndrome), cartilage, and bone marrow. Skin symptoms have been poorly described.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom